593 related articles for article (PubMed ID: 31315045)
1. Deficiency in BDNF/TrkB Neurotrophic Activity Stimulates δ-Secretase by Upregulating C/EBPβ in Alzheimer's Disease.
Wang ZH; Xiang J; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Wu S; Wang JZ; Ye K
Cell Rep; 2019 Jul; 28(3):655-669.e5. PubMed ID: 31315045
[TBL] [Abstract][Full Text] [Related]
2. Spatiotemporal activation of the C/EBPβ/δ-secretase axis regulates the pathogenesis of Alzheimer's disease.
Wang H; Liu X; Chen S; Ye K
Proc Natl Acad Sci U S A; 2018 Dec; 115(52):E12427-E12434. PubMed ID: 30530690
[TBL] [Abstract][Full Text] [Related]
3. Delta-secretase-cleaved Tau antagonizes TrkB neurotrophic signalings, mediating Alzheimer's disease pathologies.
Xiang J; Wang ZH; Ahn EH; Liu X; Yu SP; Manfredsson FP; Sandoval IM; Ju G; Wu S; Ye K
Proc Natl Acad Sci U S A; 2019 Apr; 116(18):9094-9102. PubMed ID: 31004063
[TBL] [Abstract][Full Text] [Related]
4. C/EBPβ regulates delta-secretase expression and mediates pathogenesis in mouse models of Alzheimer's disease.
Wang ZH; Gong K; Liu X; Zhang Z; Sun X; Wei ZZ; Yu SP; Manfredsson FP; Sandoval IM; Johnson PF; Jia J; Wang JZ; Ye K
Nat Commun; 2018 May; 9(1):1784. PubMed ID: 29725016
[TBL] [Abstract][Full Text] [Related]
5. Neurotrophic signaling deficiency exacerbates environmental risks for Alzheimer's disease pathogenesis.
Wu Z; Chen C; Kang SS; Liu X; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Proc Natl Acad Sci U S A; 2021 Jun; 118(25):. PubMed ID: 34140411
[TBL] [Abstract][Full Text] [Related]
6. TrkB receptor cleavage by delta-secretase abolishes its phosphorylation of APP, aggravating Alzheimer's disease pathologies.
Xia Y; Wang ZH; Liu P; Edgington-Mitchell L; Liu X; Wang XC; Ye K
Mol Psychiatry; 2021 Jul; 26(7):2943-2963. PubMed ID: 32782380
[TBL] [Abstract][Full Text] [Related]
7. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
8. Brain-derived neurotrophic factor and TrkB expression in the "oldest-old," the 90+ Study: correlation with cognitive status and levels of soluble amyloid-beta.
Michalski B; Corrada MM; Kawas CH; Fahnestock M
Neurobiol Aging; 2015 Dec; 36(12):3130-3139. PubMed ID: 26410307
[TBL] [Abstract][Full Text] [Related]
9. Targeting both BDNF/TrkB pathway and delta-secretase for treating Alzheimer's disease.
Liao J; Chen C; Ahn EH; Liu X; Li H; Edgington-Mitchell LE; Lu Z; Ming S; Ye K
Neuropharmacology; 2021 Oct; 197():108737. PubMed ID: 34343610
[TBL] [Abstract][Full Text] [Related]
10. Gut inflammation triggers C/EBPβ/δ-secretase-dependent gut-to-brain propagation of Aβ and Tau fibrils in Alzheimer's disease.
Chen C; Zhou Y; Wang H; Alam A; Kang SS; Ahn EH; Liu X; Jia J; Ye K
EMBO J; 2021 Sep; 40(17):e106320. PubMed ID: 34260075
[TBL] [Abstract][Full Text] [Related]
11. Neuronal ApoE4 stimulates C/EBPβ activation, promoting Alzheimer's disease pathology in a mouse model.
Wang ZH; Xia Y; Wu Z; Kang SS; Zhang JC; Liu P; Liu X; Song W; Huin V; Dhaenens CM; Yu SP; Wang XC; Ye K
Prog Neurobiol; 2022 Feb; 209():102212. PubMed ID: 34958873
[TBL] [Abstract][Full Text] [Related]
12. 7,8-dihydroxyflavone, a small-molecule TrkB agonist, reverses memory deficits and BACE1 elevation in a mouse model of Alzheimer's disease.
Devi L; Ohno M
Neuropsychopharmacology; 2012 Jan; 37(2):434-44. PubMed ID: 21900882
[TBL] [Abstract][Full Text] [Related]
13. δ-Secretase-cleaved Tau stimulates Aβ production via upregulating STAT1-BACE1 signaling in Alzheimer's disease.
Zhang Z; Li XG; Wang ZH; Song M; Yu SP; Kang SS; Liu X; Zhang Z; Xie M; Liu GP; Wang JZ; Ye K
Mol Psychiatry; 2021 Feb; 26(2):586-603. PubMed ID: 30382187
[TBL] [Abstract][Full Text] [Related]
14. Serum pro-BDNF levels correlate with phospho-tau staining in Alzheimer's disease.
Bharani KL; Ledreux A; Gilmore A; Carroll SL; Granholm AC
Neurobiol Aging; 2020 Mar; 87():49-59. PubMed ID: 31882186
[TBL] [Abstract][Full Text] [Related]
15. TrkB reduction exacerbates Alzheimer's disease-like signaling aberrations and memory deficits without affecting β-amyloidosis in 5XFAD mice.
Devi L; Ohno M
Transl Psychiatry; 2015 May; 5(5):e562. PubMed ID: 25942043
[TBL] [Abstract][Full Text] [Related]
16. A delta-secretase-truncated APP fragment activates CEBPB, mediating Alzheimer's disease pathologies.
Yao Y; Kang SS; Xia Y; Wang ZH; Liu X; Muller T; Sun YE; Ye K
Brain; 2021 Jul; 144(6):1833-1852. PubMed ID: 33880508
[TBL] [Abstract][Full Text] [Related]
17. ApoE4 activates C/EBPβ/δ-secretase with 27-hydroxycholesterol, driving the pathogenesis of Alzheimer's disease.
Wang ZH; Xia Y; Liu P; Liu X; Edgington-Mitchell L; Lei K; Yu SP; Wang XC; Ye K
Prog Neurobiol; 2021 Jul; 202():102032. PubMed ID: 33716161
[TBL] [Abstract][Full Text] [Related]
18. 3,6'-Disinapoylsucrose alleviates the amyloid precursor protein and lipopolysaccharide induced cognitive dysfunction through upregulation of the TrkB/BDNF pathway.
Wang YT; Wang H; Ren WJ; Dai XL; Huo Q; Wang S; Sun YX
J Asian Nat Prod Res; 2023 Apr; 25(4):387-402. PubMed ID: 35672874
[TBL] [Abstract][Full Text] [Related]
19. Cholesterol overload induces apoptosis in SH-SY5Y human neuroblastoma cells through the up regulation of flotillin-2 in the lipid raft and the activation of BDNF/Trkb signaling.
Huang YN; Lin CI; Liao H; Liu CY; Chen YH; Chiu WC; Lin SH
Neuroscience; 2016 Jul; 328():201-9. PubMed ID: 27155148
[TBL] [Abstract][Full Text] [Related]
20. Optimized TrkB Agonist Ameliorates Alzheimer's Disease Pathologies and Improves Cognitive Functions via Inhibiting Delta-Secretase.
Chen C; Ahn EH; Liu X; Wang ZH; Luo S; Liao J; Ye K
ACS Chem Neurosci; 2021 Jul; 12(13):2448-2461. PubMed ID: 34106682
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
